On Tuesday, Following Stocks were among the “Top 100 Losers” In U.S. Stock Exchange: Bristol-Myers Squibb (NYSE:BMY), Finisar (NASDAQ:FNSR), Tyson Foods, (NYSE:TSN), ARRIS Group, (NASDAQ:ARRS)
On Wed, Mar 25, 2015 Bristol-Myers Squibb Co (NYSE:BMY) proclaimed the company has signed an agreement with Novo Nordisk under which Bristol-Myers Squibb will acquire an exclusive global license to a discovery biologics research program focused on modulating the innate immune system as a therapy for autoimmune diseases. Terms of the contract were not revealed.
The contract supports Bristol-Myers Squibb’s long-standing commitment to immunoscience, a core therapeutic area with multiple innovative drug candidates in development to target immune-mediated diseases with high unmet medical needs.
Bristol-Myers Squibb Co (NYSE:BMY)’s shares picked down -2.80%, and closed at $65.69. The stock volatility for the week is 1.95%, while for the month remained 2.07%. The company holds consensus target price of $65.04.
If we consider EPS growth of the company, then the company indicated the following observations:
The company showed 1.20 diluted EPS growth for trailing twelve months. However, YTD EPS growth remained -22.10% and Annual EPS growth for the past 5 years is considered as -5.90%.
The mean recommendation of analysts for this stock is 2.30. (Where 1=Buy, 5=Sale).
Bristol-Myers Squibb Co (BMY) discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It provides chemically-synthesized drugs or small molecules, and biologics in various therapeutic areas, counting virology comprising human immunodeficiency virus infection (HIV); oncology; neuroscience; immunoscience; and cardiovascular.
On Wed, Mar 25, 2015 Finisar Corporation (NASDAQ:FNSR) introduced multiple new products, counting a variety of optical modules based on the 100G QSFP28 MSA form factor, in addition to the industry’s first 25G Ethernet SFP28-SR transceiver, based on the SFP+ form-factor. The optical modules are designed for 100G Ethernet applications within the data center. The product portfolio comprises the industry’s first 100G-CWDM4 module, the first 100GBASE-LR4 module under 3.5W, and a 100GBASE-SR4 module breaking-out to four SFP28-SR modules. Demonstrations of these products will take place during the OFC exhibition in Finisar’s booth #1403 at the Los Angeles Convention Center, March 24-26, 2015.
Finisar Corporation (NASDAQ:FNSR) declined -2.75%, and closed at $22.47. The company has the market capitalization of $2.40 billion. The beta value of the stock is 1.94. On the other hand the stock’s volatility for the week is 2.79%, and for the month is 2.74%. The stock’s price to book ratio is $2.15, however price to sale ratio is $1.89. Analyst’s mean recommendation regarding this stock is 2.50. (Where 1=Buy, 5=Sale).
Finisar Corporation (FNSR) offers optical subsystems and components for data communication and telecommunication applications in the United States, Malaysia, China, and internationally.
Formerly On Date Tyson Foods, Inc. (NYSE:TSN) plans to tell analysts that its branded product portfolio, operational execution and synergy capture from the attainment of Hillshire Brands give it the confidence to reiterate its fiscal 2015 guidance of $3.30 to $3.40 adjusted earnings per share.
Tyson Foods, Inc. (NYSE:TSN) decreased -2.76%, and closed at $38.70. The company holds the market capitalization of $14.91 billion. For the last twelve months, the stock was able to keep return on equity at 11.80%, while return on assets at -5.10%, in response to its return on investment at 6.10%. Its 20-day moving average decreased -3.38%, below 50-day moving average of -3.63%, above 200-day moving average of -1.29% from the latest market price of $38.70. The mean recommendation of analysts for this stock is 1.80. (Where 1=Buy, 5=Sale).
Tyson Foods, Inc. (TSN) along with its auxiliaries, produces, distributes, and markets chicken, beef, pork, prepared foods, and related allied products worldwide. The corporation breeds and raises chickens; and processes live chickens into fresh, frozen, and value-added chicken products.
Formerly On March 16, 2015 ARRIS Group, Inc. (NASDAQ:ARRS) The ARRIS E6000 CER delivers new levels of density and cost-effectiveness in a simple, robust integrated architecture that will enable converged services on broadband networks. It also provides a high-availability, high-performance solution, and supports a fully redundant design.
ARRIS Group, Inc. (NASDAQ:ARRS) fell -2.75%, and closed at $30.09. The stock has the beta value of 1.04, and its volatility for the week is 2.08%, while for the month it is 2.10%. The company has the market capitalization of $4.49 billion. The company holds the book value per share of 11.64, whereas cash per share is 4.77. Price to book ratio remained 2.59, while price to sale ratio is 0.82. Analysts mean recommendation for the stock is said to be 1.90 (where 1=Buy, 5=sale).
ARRIS Group, Inc. (ARRS) offers media entertainment and data communications solutions in the United States and internationally. The company operates in two segments, Customer Premises Equipment and Network & Cloud. The Customer Premises Equipment segment offers various product solutions, including set-top boxes, gateways, digital subscriber lines and cable modems, and embedded multimedia terminal adapters and voice/data modems that enable service providers to offer voice, video, and high-speed data services to residential and business subscribers.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The data demonstrated in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
